Suppr超能文献

血管共病与阿尔茨海默病进展的关联:挪威记忆诊所的一项为期两年的观察性研究。

Association between vascular comorbidity and progression of Alzheimer's disease: a two-year observational study in Norwegian memory clinics.

机构信息

Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), 7491, Trondheim, Norway.

Department of Geriatrics, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

出版信息

BMC Geriatr. 2018 May 22;18(1):120. doi: 10.1186/s12877-018-0813-4.

Abstract

BACKGROUND

Vascular risk factors increase the risk of Alzheimer's disease (AD), but there is limited evidence on whether comorbid vascular conditions and risk factors have an impact on disease progression. The aim of this study was to examine the association between vascular disease and vascular risk factors and progression of AD.

METHODS

In a longitudinal observational study in three Norwegian memory clinics, 282 AD patients (mean age 73.3 years, 54% female) were followed for mean 24 (16-37) months. Vascular risk factors and vascular diseases were registered at baseline, and the vascular burden was estimated by the Framingham Stroke Risk Profile (FSRP). Cerebral medical resonance images (MRIs) were assessed for white matter hyperintensities (WMH), lacunar and cortical infarcts. The associations between vascular comorbidity and progression of dementia as measured by annual change in Clinical Dementia Rating Sum of Boxes (CDR-SB) scores were analysed by multiple regression analyses, adjusted for age and sex.

RESULTS

Hypertension occurred in 83%, hypercholesterolemia in 53%, diabetes in 9%, 41% were overweight, and 10% were smokers. One third had a history of vascular disease; 16% had heart disease and 15% had experienced a cerebrovascular event. MRI showed lacunar infarcts in 16%, WMH with Fazekas score 2 in 26%, and Fazekas score 3 in 33%. Neither the vascular risk factors and diseases, the FSRP score, nor cerebrovascular disease was associated with disease progression in AD.

CONCLUSIONS

Although vascular risk factors and vascular diseases were prevalent, no impact on the progression of AD after 2 years was shown.

摘要

背景

血管危险因素会增加阿尔茨海默病(AD)的风险,但关于合并血管疾病和危险因素是否会影响疾病进展的证据有限。本研究旨在探讨血管疾病和血管危险因素与 AD 进展之间的关系。

方法

在挪威三个记忆诊所的一项纵向观察性研究中,对 282 名 AD 患者(平均年龄 73.3 岁,54%为女性)进行了平均 24(16-37)个月的随访。在基线时登记了血管危险因素和血管疾病,并通过 Framingham 中风风险评分(FSRP)估计血管负担。对脑磁共振成像(MRI)进行评估,以测量脑白质高信号(WMH)、腔隙性和皮质性梗死。通过多元回归分析,调整年龄和性别后,分析血管合并症与痴呆进展(以年度变化的临床痴呆评定量表总和评分(CDR-SB)表示)之间的关系。

结果

83%的患者患有高血压,53%的患者患有高胆固醇血症,9%的患者患有糖尿病,41%的患者超重,10%的患者吸烟。三分之一的患者有血管疾病史;16%的患者患有心脏病,15%的患者曾经历过脑血管事件。MRI 显示腔隙性梗死 16%,Fazekas 评分 2 的 WMH 26%,Fazekas 评分 3 的 33%。血管危险因素和疾病、FSRP 评分以及脑血管疾病均与 AD 进展无关。

结论

尽管血管危险因素和血管疾病很普遍,但在 2 年后未显示出对 AD 进展有影响。

相似文献

2
Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics.
J Alzheimers Dis. 2018;61(3):1221-1232. doi: 10.3233/JAD-170436.
5
White matter hyperintensities and imaging patterns of brain ageing in the general population.
Brain. 2016 Apr;139(Pt 4):1164-79. doi: 10.1093/brain/aww008. Epub 2016 Feb 24.
6
9
Baseline predictors of cognitive decline in patients with cerebral small vessel disease.
J Alzheimers Dis. 2014;42 Suppl 3:S37-43. doi: 10.3233/JAD-132606.

引用本文的文献

3
Multimorbidity measures associated with cognitive function among community-dwelling older Chinese adults.
Alzheimers Dement. 2024 Sep;20(9):6221-6231. doi: 10.1002/alz.14117. Epub 2024 Jul 27.
4
Innervation of adipocytes is limited in mouse perivascular adipose tissue.
Am J Physiol Heart Circ Physiol. 2024 Jul 1;327(1):H155-H181. doi: 10.1152/ajpheart.00041.2024. Epub 2024 May 24.
5
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
9
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.
Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25.

本文引用的文献

1
Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics.
J Alzheimers Dis. 2018;61(3):1221-1232. doi: 10.3233/JAD-170436.
2
Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study.
Neurology. 2017 Nov 28;89(22):2262-2270. doi: 10.1212/WNL.0000000000004688. Epub 2017 Nov 1.
4
Dementia prevention, intervention, and care.
Lancet. 2017 Dec 16;390(10113):2673-2734. doi: 10.1016/S0140-6736(17)31363-6. Epub 2017 Jul 20.
5
Body Mass Index and Risk of Alzheimer's Disease: A Mendelian Randomization Study of 399,536 Individuals.
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2310-2320. doi: 10.1210/jc.2017-00195.
7
The frequency and influence of dementia risk factors in prodromal Alzheimer's disease.
Neurobiol Aging. 2017 Aug;56:33-40. doi: 10.1016/j.neurobiolaging.2017.03.034. Epub 2017 Apr 8.
8
Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.
JAMA. 2017 Apr 11;317(14):1443-1450. doi: 10.1001/jama.2017.3090.
9
Early-onset and delayed-onset poststroke dementia - revisiting the mechanisms.
Nat Rev Neurol. 2017 Mar;13(3):148-159. doi: 10.1038/nrneurol.2017.16. Epub 2017 Feb 17.
10
Revised Framingham Stroke Risk Profile to Reflect Temporal Trends.
Circulation. 2017 Mar 21;135(12):1145-1159. doi: 10.1161/CIRCULATIONAHA.115.021275. Epub 2017 Feb 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验